focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.70
Bid: 4.50
Ask: 4.90
Change: 0.00 (0.00%)
Spread: 0.40 (8.889%)
Open: 4.75
High: 4.80
Low: 4.70
Prev. Close: 4.70
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on legal actions

2 Apr 2024 15:33

RNS Number : 0228J
DCI Advisors Limited
02 April 2024
 

DCI Advisors Limited

(the "Company" or "DCI")

Update on legal actions with Dolphin Capital Partners Limited

 

2 April 2024

 

Following the Company's litigation update published on 28 March 2024, the Board of DCI has been made aware that its former manager, Dolphin Capital Partners Limited ("DCP"), has contacted a number of DCI's shareholders with claims that the litigation being pursued by DCI against DCP could prove unaffordable for DCI. Following receipt of such communication from DCP, one shareholder has even suggested that DCI obtains third party funding for its litigation against DCP.

 

The DCI board therefore wishes to advise shareholders that it started exploring litigation funding for most of its litigation against DCP from a third party in 2023, with a funding agreement signed earlier this year.

 

Further, concerning DCI's litigation against DCP and individuals associated with DCP in Greece, DCI has the funding in place to carry the litigation to its conclusion, with a maximum cost to DCI estimated at approximately €100,000. DCI's directors believe that for such a modest cost it is overwhelmingly in the best interest of shareholders as a whole that this litigation is pursued, as the advice provided to the Company is that the financial upside the Company could expect from success is currently c.€57.0 million, with the potential for this amount to increase. The litigation funding that DCI has secured will mitigate DCI's legal costs in pursuing this claim and means that DCI is well positioned to continue to their conclusion all its legal cases and claims against DCP.

 

The Board of DCI would also like to use this opportunity to respond to DCP's misleading statement that this €57.0 million claim only relates to the Amanzoe option. This is incorrect. Many different claims have been made and these are unrelated to the Amanzoe option.

 

The Directors anticipate that they will release a general update on DCI and its portfolio next week.

 

Enquiries

DCI Advisors Ltd

Nicolai Huls / Nick Paris, Managing Directors

 

nickparis@btinternet.com

+44 (0) 7738 470550

Cavendish Capital Markets (Nominated Adviser & Broker)

James King / Jonny Franklin‐Adams / Edward Whiley / Oscar Valeur‐Adu (Corporate Finance)

Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDITMITMTJMBTI
Date   Source Headline
15th Nov 20162:05 pmRNSSecond Price Monitoring Extn
15th Nov 20162:00 pmRNSPrice Monitoring Extension
15th Nov 20167:00 amRNSDisposal
25th Oct 20167:00 amRNSPosting of Half Yearly Report
30th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20167:00 amRNSNotice of Results
19th Jul 20169:23 amRNSDirector Declaration - Additional Directorship
19th Jul 20167:00 amRNSAppointment of Non-Executive Director
15th Jul 20163:06 pmRNSDirector/PDMR Shareholding
5th Jul 20165:00 pmRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSFinal Results
21st Mar 20164:35 pmRNSPrice Monitoring Extension
1st Mar 20163:37 pmRNSDirectorate Change
1st Mar 20163:34 pmRNSDirectorate Change
11th Feb 20167:00 amRNSQ4 2015 Trading Update
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:35 pmRNSPrice Monitoring Extension
28th Jan 20168:24 amRNSNotice of Q4 2015 Trading Update
30th Dec 20157:00 amRNSRetirement of Director
20th Oct 20157:00 amRNSPosting of Half Yearly Report
12th Oct 20157:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
7th Oct 201510:25 amRNSReplacement: Holding(s) in Company
7th Oct 20159:38 amRNSHolding(s) in Company
6th Oct 20157:00 amRNSAppointment of Andrew Coppel CBE to Board
25th Sep 20153:41 pmRNSHolding(s) in Company
24th Sep 20157:00 amRNSHalf Yearly Report
15th Sep 20157:00 amRNSNotice of Results
30th Jul 20157:01 amRNSQ2 Trading Update
8th Jul 20159:00 amRNS2014 Annual Report and Accounts
30th Jun 20157:00 amRNSUpdate re capital controls measures in Greece
16th Jun 201512:40 pmRNSHolding(s) in Company
15th Jun 20152:34 pmRNSHolding(s) in Company
11th Jun 20155:05 pmRNSHolding(s) in Company
11th Jun 20155:02 pmRNSHolding(s) in Company
11th Jun 20155:00 pmRNSHolding(s) in Company
11th Jun 20154:59 pmRNSHolding(s) in Company
11th Jun 20158:00 amRNSAdmission of new Shares
5th Jun 20155:37 pmRNSPASSING OF WRITTEN RESOLUTION
4th Jun 20158:00 amRNSResults of Placing Announcement
3rd Jun 20157:00 amRNSProposed Issue of New Shares to raise EUR75 m
3rd Jun 20157:00 amRNSFinal Results
25th Feb 20157:02 amRNSDirectorate Changes and Review of Strategy
18th Feb 201511:09 amRNSHolding(s) in Company
4th Dec 20147:00 amRNSQ3 Trading Update
27th Nov 20149:00 amRNSNotice of Results
12th Nov 20147:00 amRNSClosing of $30.5m investment into Playa Grande
23rd Oct 20148:00 amRNSPosting of Half Yearly Report
23rd Sep 20147:00 amRNSHalf Yearly Report
12th Sep 201411:37 amRNSNotice of Results
8th Aug 20147:00 amRNSClosing of Investment into Amanzoe

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.